Professor Gordon Cook - NIHR Leeds MIC

Home | Team Members | Professor Gordon Cook

Professor Gordon Cook

Oncology

Oncology

Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort

View Publication

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

View Publication

Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial. Leukemia

View Publication

International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials

View Publication

Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma Network

View Publication

Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with Multiple Myeloma receiving systemic anti-cancer therapy.

View Publication

Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

View Publication

Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with Multiple Myeloma receiving systemic anti-cancer therapy

View Publication

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

View Publication

Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients

View Publication

Myeloma and the impact of COVID-19